Pulmonx (LUNG) Change in Cash (2019 - 2025)
Pulmonx's (LUNG) quarterly Change in Cash came in at $1.1 million in Q3 2025, up 818.54% year-on-year from $118121.8 in Q3 2024, and up 18.84% on a QoQ basis from $913000.0 in Q2 2025.
Pulmonx (LUNG) Change in Cash (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Change in Cash data on file, last reported at $1.1 million in Q3 2025.
- On a quarterly basis, Change in Cash rose 818.54% year-over-year to $1.1 million in Q3 2025; TTM through Sep 2025 was $13.2 million, a 141.88% increase from a year earlier, with the FY2024 full-year figure at -$12.6 million, up 30.58% from the prior year.
- Change in Cash for Q3 2025 stood at $1.1 million, up from $913000.0 in the prior quarter.
- Over the last five years, Change in Cash for LUNG reached as high as $8.7 million in Q1 2023 and fell as low as -$39.6 million in Q4 2021.
- Historically, Change in Cash has averaged -$8.2 million across 5 years, with a median of -$8.6 million in 2023.
- Across the five-year window, Change in Cash sank 1406.63% in 2021 and surged 818.54% in 2025, its largest moves.
- Year by year, Change in Cash stood at -$39.6 million in 2021, then soared by 73.06% to -$10.7 million in 2022, then decreased by 6.85% to -$11.4 million in 2023, then surged by 166.61% to $7.6 million in 2024, then plunged by 85.71% to $1.1 million in 2025.
- Per Business Quant data, the three most recent Change in Cash figures were $1.1 million in Q3 2025, $913000.0 in Q2 2025, and $3.6 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.72 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.13 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -504.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -492.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Pulmonx | 49.94 Mn | -19.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 913,000.00 |
| Mar 31, 2025 | 3.65 Mn |
| Dec 31, 2024 | 7.59 Mn |
| Sep 30, 2024 | -151,000.00 |
| Jun 30, 2024 | -6.67 Mn |
| Mar 31, 2024 | -13.39 Mn |
| Dec 31, 2023 | -11.40 Mn |
| Sep 30, 2023 | -6.87 Mn |
| Jun 30, 2023 | -8.59 Mn |
| Mar 31, 2023 | 8.67 Mn |
| Dec 31, 2022 | -10.67 Mn |
| Sep 30, 2022 | -9.55 Mn |
| Jun 30, 2022 | -7.22 Mn |
| Mar 31, 2022 | -19.31 Mn |
| Dec 31, 2021 | -39.60 Mn |
| Sep 30, 2021 | -10.63 Mn |
| Jun 30, 2021 | -10.58 Mn |
| Mar 31, 2021 | -22.28 Mn |
| Dec 31, 2020 | 191.76 Mn |